Dr Abbas Amini is an assistant professor at the Australian College of ACK and Western Sydney University, and the member of graduate supervisory board. After obtaining PhD, he conducted research with other Australian universities, as a postdoctoral research fellow at Monash and Deakin Universities, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas is the editor of ten reputed journals, and the committee member of 20 international conferences.

Bionanotech

Dr. Olha V. Storchylo graduated Odessa State University (Ukraine) at biochemistry in 1983. She completed her post-graduate in human and animal physiology and biochemistry at the Institute of Physiology Pavlov named of Academy of Sciences of USSR in 1988 and joined the Human and Animal Physiology Department of Odessa State University as an Assistant Professor. From 2008 until now, she is an Associate Professor of Medical Chemistry Department of Odessa National Medical University.

nutrition, digestion and absorption in the small intestine and effects of milk thistle fruits on it, total body irradiation, radio pharmacology, transgenerational phenomenon, nutrigenomics, pharmacological correction and prevention of radiation effects.

Kenji Suzuki, Ph.D. (by Published Work; Nagoya University) worked at Hitachi Medical Corporation, Japan, Aichi Prefectural University, Japan, as a faculty member. He joined Department of Radiology, University of Chicago, in 2001, and he was Assistant Professor in the department and Graduate Program in Medical Physics. In 2014, he joined Department of Electric and Computer Engineering and Medical Imaging Research Center, Illinois Institute of Technology, as Associate Professor. In 2017, he was jointly appointed in World Research Hub Initiative at Tokyo Institute of Technology as Full Professor (Specially Appointed). He published more than 320 papers (including 110 peer-reviewed papers in leading journals). His papers were cited more than 9,000 times by other researchers. He has an h-index of 42. He is inventor on 30 patents (including 13 granted patents), which were licensed to several companies and commercialized. He published 10 books and 22 book chapters, and edited 13 journal special issues. He was awarded/co-awarded more than 25 grants as PI including NIH R01 and ACS. He served as the Editor of a number of leading international journals, including Pattern Recognition and Medical Physics. He served as a referee for 80 international journals, an organizer of 30 international conferences, and a program committee member of 150 international conferences. He gave 95 invited talks and keynote speeches at international conferences and universities. His research was covered in 45 articles in international newspapers, magazines and journals by press and media. He received 25 awards, including 3 RSNA Certificate of Merit Awards, IEEE Outstanding Member Award, Cancer Research Foundation Young Investigator Award, Kurt Rossmann Award for Excellence in Teaching from Univ of Chicago, IEICE 2014 Best Journal Paper Award, Springer-Nature EANM Most Cited Journal Paper Award 2016, and Marquis Who’s Who 2017 Albert Nelson Marquis Lifetime Achievement Award.

Radiology

Dr. Yusuf TUTAR is the Head of Biochemistry Division and the head of Basic Sciences Department at Faculty of Pharmacy, Cumhuriyet University, Sivas Turkey. Dr. Tutar is also the Head of Biomedical Engineering Program at the same university. He obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.

Investigating structure-function relationship of biological macromolecules with biochemical, biophysical, genetics and molecular biological methods. Recombinant DNA technology, molecular sub-cloning, transformation and protein expression. Protein purification (Heat shock, Catabolite repressor ve S100P proteins) and characterisation (Spectroscopy: Fluorescence, Luminescence, CD, FTIR; Calorimetry: NanoDSC and ITC; Chromatography: HPLC and FPLC; Other techniques: MALDI-TOF, GC). Molecular Cancer Research (Prostate, thyroid, renal, colon) and epigenetic (RT-PCR and Microarray). • MicroRNA, pseudogens and transfection. Prion, translation termination in eukaryotes, and transcription initiation in prokaryotes.

Dr. Farid Menaa is an experienced and renowned international scientist with interdisciplinary and multidisciplinary knowledge and a medical holistic point of view. He is the head of the oncology, stem cells, genomics and nanomedicine Department, Fluorotronics USA, Inc. and Global Innovation & Trade, Inc., San Diego, CA, USA. Dr. Menaa also collaborates as a project coordinator and R&D consultant for several worldwide institutions including universities, biotechnology, chemical, nanotechnological and pharmaceutical companies. He is often invited as a keynote or featured speaker and session chairman in various scientific, medical, technological and business events. Dr. Menaa earned a BSc in Biomedicine and Biochemistry, a BSc in Cell Biology and Physiology, a Master in Genetics, a National Master in Gerontology, a Doctorate in Radiation oncology and Gerontology, all with honors from prestigious French Universities. Dr. Menaa has also been trained in medicine, pharmacology and pharmaceutical sciences, chemistry/biochemistry, biophysics, genomics, immunology, nutrition, phytomedicine, biostatistics, bioinformatics, nanotechnology and business (Executive MBA). Dr. Menaa pursued his post-doctoral formation as principal investigator in Oncology (La Jolla, CA, USA), Dermatology (Wuerzburg, Germany) and in Hematology (São Paulo, Brazil). Dr. Menaa has organized and attended hundreds of scientific events (> 200), delivered lectures to many private organizations and academic institutions (>30), and further serves the scientific and medical communities as editor and reviewer for many esteemed journals (>60). Dr. Menaa is the recipient of several awards (>10), a member of prestigious scientific and medical associations (>10) and has published dozens of articles as first-author and/or corresponding author, including in the pharmaceutical sciences field.

The main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy.

Dr. Yan finished his Ph.D. in pharmacology in Weill Graduate school of Cornell medical College. He was trained in NYP/Cornell for clinical radiation oncology. He subsequently held faculty appointments at New York-Presbyterian Hospital and New York Hospital Queens. He also served as an assistant professor of clinical radiology at the Weill Cornell Medical College of Cornell University. Dr. Yan's specialties are head and neck cancers, lung cancer, lymphoma and GI cancers. In addition, Yan has extensive training in Stereotactic Radiation Therapy, in which high-dose radiotherapy beams are aimed at a tumor from many different directions with a high level of precision. He is also the director of the CyberKnife Robotic Radiotherapy System at Mitchell cancer Institute at the University of South Alabama.

Major interests are combining Lattice radiation therapy with immunotherapy and the influence of musical therapy on immune responses in patients receiving radiation therapy.

Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmasists of America. the award of Austrian Society of sanitary, hygiene and public health services and others.

Heart Disease Research ,Acupuncture & Electro-Therapeutics Research, Integrated Medicine

Cain is a consultant and administrator specializing in interim work as a clinical administrator in allied health. He has completed postgraduate and post-doctoral work in several areas including management science and business administration. Doctorate in Business Administration from Warren University.

Research interests include staff and community engagement, behaviour modification, and ways of measuring productivity and its impact on quality of care.